Heterozygous alpha 1 antitrypsin mutations (HA1AT) and lung cancer (LC) in a chronic obstructive pulmonary disease (COPD) population.
A. Marín Muñiz (L'Hospitalet de Llobregat, Spain), L. Méndez Mangas (L'Hospitalet de Llobregat, Spain), M. Navarro Rodríguez (L'Hospitalet de Llobregat, Spain), J. Burgos Lozano (L'Hospitalet de Llobregat, Spain), I. Brao Pérez (L'Hospitalet de Llobregat, Spain), M. Arellano Vengoechea (L'Hospitalet de Llobregat, Spain), M. López Sánchez (L'Hospitalet de Llobregat, Spain), S. Padrones Sánchez (L'Hospitalet de Llobregat, Spain), S. Aso González (L'Hospitalet de Llobregat, Spain), S. Santos Pérez (L'Hospitalet de Llobregat, Spain)
Source: International Congress 2022 – Alpha-1 antitrypsin deficiency and chronic airway obstructive diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Marín Muñiz (L'Hospitalet de Llobregat, Spain), L. Méndez Mangas (L'Hospitalet de Llobregat, Spain), M. Navarro Rodríguez (L'Hospitalet de Llobregat, Spain), J. Burgos Lozano (L'Hospitalet de Llobregat, Spain), I. Brao Pérez (L'Hospitalet de Llobregat, Spain), M. Arellano Vengoechea (L'Hospitalet de Llobregat, Spain), M. López Sánchez (L'Hospitalet de Llobregat, Spain), S. Padrones Sánchez (L'Hospitalet de Llobregat, Spain), S. Aso González (L'Hospitalet de Llobregat, Spain), S. Santos Pérez (L'Hospitalet de Llobregat, Spain). Heterozygous alpha 1 antitrypsin mutations (HA1AT) and lung cancer (LC) in a chronic obstructive pulmonary disease (COPD) population.. 2434
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|